In summary, we showed that pretreatment of human prostate cancer cells with cisplatin or LA-12 resulted in significant potentiation of TRAIL-induced cell death via engagement of mitochondrial apoptotic pathway, associated with pronounced Bid cleavage, Bak activation, loss of MMP and caspase activation. The gene discussed is BAK1; the disease is Familial prostate cancer.